Literature DB >> 21288111

More on aprepitant for erlotinib-induced pruritus.

Olivier Mir, Benoit Blanchet, François Goldwasser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288111     DOI: 10.1056/NEJMc1013027

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Aprepitant and fosaprepitant drug interactions: a systematic review.

Authors:  Priya Patel; J Steven Leeder; Micheline Piquette-Miller; L Lee Dupuis
Journal:  Br J Clin Pharmacol       Date:  2017-06-10       Impact factor: 4.335

Review 2.  Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.

Authors:  Andrea L Suárez; Jamison D Feramisco; John Koo; Martin Steinhoff
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

3.  TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis.

Authors:  Boyi Liu; Jasmine Escalera; Shrilatha Balakrishna; Lu Fan; Ana I Caceres; Eve Robinson; Aiwei Sui; M Craig McKay; M Allen McAlexander; Christina A Herrick; Sven E Jordt
Journal:  FASEB J       Date:  2013-05-30       Impact factor: 5.191

4.  Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.

Authors:  Johanna S Song; Marianne Tawa; Nicole G Chau; Thomas S Kupper; Nicole R LeBoeuf
Journal:  BMC Cancer       Date:  2017-03-16       Impact factor: 4.430

Review 5.  NK-1 Receptor Antagonists and Pruritus: Review of Current Literature.

Authors:  Marcelina Pojawa-Gołąb; Kamila Jaworecka; Adam Reich
Journal:  Dermatol Ther (Heidelb)       Date:  2019-06-12

6.  Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial.

Authors:  Bruno Vincenzi; Mike Trower; Ajay Duggal; Pamela Guglielmini; Peter Harris; David Jackson; Mario E Lacouture; Emiliangelo Ratti; Giuseppe Tonini; Andrew Wood; Sonja Ständer
Journal:  BMJ Open       Date:  2020-02-06       Impact factor: 2.692

Review 7.  Aprepitant for the Treatment of Chronic Refractory Pruritus.

Authors:  Alice He; Jihad M Alhariri; Ronald J Sweren; Madan M Kwatra; Shawn G Kwatra
Journal:  Biomed Res Int       Date:  2017-09-19       Impact factor: 3.411

8.  Treatment of severe rash caused by crizotinib with both traditional Chinese medicine and Western medicine: Two case reports and literature review.

Authors:  Shu-Yue Zheng; Wen Shen; Yan-Mei Peng; Hui-Juan Cui; Hua Duan; Yu-Qin Qiu; Qiang Li; Jing-Yi Zhang; Chen-Yao Sun; Xu Zhang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.